Amyn Bhamani, Evangelos Katsampouris, Fanta Bojang, Priyam Verghese, Andrew Creamer, Ruth Prendecki, Chuen R Khaw, Jennifer L Dickson, Carolyn Horst, Sophie Tisi, Helen Hall, John McCabe, Kylie Gyertson, Anne-Marie Hacker, Laura Farrelly, Neal Navani, Allan Hackshaw, Samuel M Janes, Samantha L Quaife
{"title":"Uptake and 4-week outcomes of an 'opt-out' smoking cessation referral strategy in a London-based lung cancer screening setting.","authors":"Amyn Bhamani, Evangelos Katsampouris, Fanta Bojang, Priyam Verghese, Andrew Creamer, Ruth Prendecki, Chuen R Khaw, Jennifer L Dickson, Carolyn Horst, Sophie Tisi, Helen Hall, John McCabe, Kylie Gyertson, Anne-Marie Hacker, Laura Farrelly, Neal Navani, Allan Hackshaw, Samuel M Janes, Samantha L Quaife","doi":"10.1136/bmjresp-2024-002337","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Lung cancer screening (LCS) enables the delivery of smoking cessation interventions to a population experiencing long-term tobacco dependence, but the optimal delivery method remains unclear. Here, we report uptake and short-term outcomes of an 'opt-out' smoking cessation referral strategy in an LCS cohort.</p><p><strong>Methods: </strong>Individuals currently smoking tobacco who attended a face-to-face lung health check in the SUMMIT study (NCT03934866) were offered very brief advice on smoking cessation and where possible, an 'opt-out' referral to their local stop smoking service (SSS). Aggregate data on referral outcomes were obtained from each SSS individually.</p><p><strong>Results: </strong>33.7% (n=2090/6203) of individuals currently smoking tobacco consented to a practitioner-made 'opt-out' smoking cessation referral. 42.7% (n=893/2090) of these individuals resided in boroughs where SSS were not present or required self-referral. Males (adjusted OR (aOR) 1.16), younger individuals (55-59: aOR 1.70, 60-64: aOR 1.71 and 65-69: aOR 1.78) and those of ethnic minority backgrounds (Asian: aOR 1.31, Black: aOR 1.71 and Mixed: aOR 1.72) were more likely to consent, while individuals from the most deprived socioeconomic quintile were less likely to do so (aOR 0.65).High level of motivation to quit within a defined time frame (aOR 1.92), previous quit attempts in the past 12 months (1-4: aOR 1.65 and ≥5: aOR 1.54) and time to first cigarette of ≤60 min (<5: aOR 2.07, 6-30: aOR 1.55 and 31-60: aOR 1.56) were measures of tobacco dependence associated with a higher likelihood of providing consent.Outcomes were available for 742 referrals. An appointment with the service was accepted by 47.3% (n=351/742) of individuals, following which 65.5% (n=230/351) set a quit date. The 4-week quit rate among those setting a quit date and all individuals referred was 57.4% (n=132/230) and 17.8% (n=132/742), respectively.</p><p><strong>Conclusion: </strong>A proactive, 'opt-out' smoking cessation referral strategy for individuals currently smoking tobacco who interact with an LCS programme may be beneficial.</p>","PeriodicalId":9048,"journal":{"name":"BMJ Open Respiratory Research","volume":"12 1","pages":""},"PeriodicalIF":3.6000,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11804203/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Open Respiratory Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/bmjresp-2024-002337","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Lung cancer screening (LCS) enables the delivery of smoking cessation interventions to a population experiencing long-term tobacco dependence, but the optimal delivery method remains unclear. Here, we report uptake and short-term outcomes of an 'opt-out' smoking cessation referral strategy in an LCS cohort.
Methods: Individuals currently smoking tobacco who attended a face-to-face lung health check in the SUMMIT study (NCT03934866) were offered very brief advice on smoking cessation and where possible, an 'opt-out' referral to their local stop smoking service (SSS). Aggregate data on referral outcomes were obtained from each SSS individually.
Results: 33.7% (n=2090/6203) of individuals currently smoking tobacco consented to a practitioner-made 'opt-out' smoking cessation referral. 42.7% (n=893/2090) of these individuals resided in boroughs where SSS were not present or required self-referral. Males (adjusted OR (aOR) 1.16), younger individuals (55-59: aOR 1.70, 60-64: aOR 1.71 and 65-69: aOR 1.78) and those of ethnic minority backgrounds (Asian: aOR 1.31, Black: aOR 1.71 and Mixed: aOR 1.72) were more likely to consent, while individuals from the most deprived socioeconomic quintile were less likely to do so (aOR 0.65).High level of motivation to quit within a defined time frame (aOR 1.92), previous quit attempts in the past 12 months (1-4: aOR 1.65 and ≥5: aOR 1.54) and time to first cigarette of ≤60 min (<5: aOR 2.07, 6-30: aOR 1.55 and 31-60: aOR 1.56) were measures of tobacco dependence associated with a higher likelihood of providing consent.Outcomes were available for 742 referrals. An appointment with the service was accepted by 47.3% (n=351/742) of individuals, following which 65.5% (n=230/351) set a quit date. The 4-week quit rate among those setting a quit date and all individuals referred was 57.4% (n=132/230) and 17.8% (n=132/742), respectively.
Conclusion: A proactive, 'opt-out' smoking cessation referral strategy for individuals currently smoking tobacco who interact with an LCS programme may be beneficial.
期刊介绍:
BMJ Open Respiratory Research is a peer-reviewed, open access journal publishing respiratory and critical care medicine. It is the sister journal to Thorax and co-owned by the British Thoracic Society and BMJ. The journal focuses on robustness of methodology and scientific rigour with less emphasis on novelty or perceived impact. BMJ Open Respiratory Research operates a rapid review process, with continuous publication online, ensuring timely, up-to-date research is available worldwide. The journal publishes review articles and all research study types: Basic science including laboratory based experiments and animal models, Pilot studies or proof of concept, Observational studies, Study protocols, Registries, Clinical trials from phase I to multicentre randomised clinical trials, Systematic reviews and meta-analyses.